An Open-Label, Pilot Trial of HRG80™ Red Ginseng in Chronic Fatigue Syndrome, Fibromyalgia, and Post-Viral Fatigue
Chronic fatigue syndrome and fibromyalgia (CFS/FMS) affect 2.1% of the world's population and ~10-25% of people who have had COVID-19. Previous clinical data suggested that a unique <i>Panax ginseng</i> (C.A. Meyer, family Araliaceae) root extract (HRG80™ Red Ginseng) often resulted...
Saved in:
Main Authors: | , |
---|---|
Format: | Bog |
Udgivet: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Fag: | |
Online adgang: | Connect to this object online. |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Internet
Connect to this object online.3rd Floor Main Library
Klassifikationsnummer: |
A1234.567 |
---|---|
Kopi 1 | Tilgængelig |